Determination of interleukin-4,-5,-6,-8 and-13 in serum of patients with breast cancer before treatment and its correlation to circulating tumor cells

Anticancer Research

Volumn 36, Issue 6, 2016, Pages 3123-3130

  König, Alexander ^a   Vilsmaier, Theresa ^a   Rack, Brigitte ^a   Friese, Klaus ^a   Janni, Wolfgang ^b   Jeschke, Udo ^a   Andergassen, Ulrich ^a   Trapp, Elisabeth ^a   Jückstock, Julia ^a   Jäger, Bernadette ^b   Alunni Fabbroni, Marianna ^a   Friedl, Thomas ^b   Weissenbacher, Tobias ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Breast cancer; Circulating tumor cells; IL 13; IL 4; IL 5; IL 6; IL 8

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIRUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; GEMCITABINE; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; PROGESTERONE RECEPTOR; ZOLEDRONIC ACID; IL4 PROTEIN, HUMAN; IL5 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; IL8 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE;

APOPTOSIS; BLOOD SAMPLING; BREAST CANCER; CANCER GRADING; CANCER MORTALITY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CIRCULATING TUMOR CELL; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); TH2 CELL; TREATMENT DURATION; BLOOD; BREAST TUMOR; IMMUNOLOGY; MORTALITY; PATHOLOGY; TUMOR EMBOLISM;

BREAST NEOPLASMS; FEMALE; HUMANS; INTERLEUKIN-13; INTERLEUKIN-4; INTERLEUKIN-5; INTERLEUKIN-6; INTERLEUKIN-8; INTERLEUKINS; LYMPHATIC METASTASIS; NEOPLASM GRADING; NEOPLASTIC CELLS, CIRCULATING;

EID: 84991677917     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (21)

1. van Dalum G, van der Stam GJ, Tibbe AG, Franken B, Mastboom WJ, Vermes I, de Groot MR and Terstappen LW: Circulating tumor cells before and during follow-up after breast cancer surgery. Int J Oncol 46(1): 407-413, 2015.
2. Rack B, Schindlbeck C, Juckstock J, Andergassen U, Hepp P, Zwingers T, Friedl TW, Lorenz R, Tesch H, Fasching PA, Fehm T, Schneeweiss A, Lichtenegger W, Beckmann MW, Friese K, Pantel K, Janni W and Group SS: Circulating tumor cells predict survival in early average-to-high risk breast cancer patients. J Natl Cancer Inst 106(5), 2014.
3. Hayes DF, Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Miller MC, Matera J, Allard WJ, Doyle GV and Terstappen LW: Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progressionfree and overall survival. Clin Cancer Res 12(14 Pt 1): 4218-4224, 2006.
4. Helal TE, Ibrahim EA and Alloub AI: Immunohistochemical analysis of tumor-infiltrating lymphocytes in breast carcinoma: Relation to prognostic variables. Indian J Pathol Microbiol 56(2): 89-93, 2013.
5. Carvalho MI, Pires I, Prada J and Queiroga FL: A role for Tlymphocytes in human breast cancer and in canine mammary tumors. Biomed Res Int 2014: 130894, 2014.
6. Visconti L, Nelissen K, Deckx L, van den Akker M, Adriaensen W, Daniels L, Mathei C, Linsen L, Hellings N, Stinissen P and Buntinx F: Prognostic value of circulating cytokines on overall survival and disease-free survival in cancer patients. Biomark Med 8(2): 297-306, 2014.
7. Gradishar WJ, Anderson BO, Balassanian R, Blair SL, Burstein HJ, Cyr A, Elias AD, Farrar WB, Forero A, Giordano SH, Goetz M, Goldstein LJ, Hudis CA, Isakoff SJ, Marcom PK, Mayer IA, McCormick B, Moran M, Patel SA, Pierce LJ, Reed EC, Salerno KE, Schwartzberg LS, Smith KL, Smith ML, Soliman H, Somlo G, Telli M, Ward JH, Shead DA and Kumar R: Invasive breast cancer version 1.2016, NCCN Clinical Practice Guidelines In Oncology. J Natl Compr Canc Netw 14(3): 324-354, 2016.
8. Elston EW and Ellis IO: Method for grading breast cancer. J Clin Pathol 46(2): 189-190, 1993.
9. Breitbart W, Rosenfeld B, Tobias K, Pessin H, Ku GY, Yuan J and Wolchok J: Depression, cytokines, and pancreatic cancer. Psychooncology 23(3): 339-345, 2014.
10. Mitsunaga S, Ikeda M, Shimizu S, Ohno I, Furuse J, Inagaki M, Higashi S, Kato H, Terao K and Ochiai A: Serum levels of il-6 and il-1beta can predict the efficacy of gemcitabine in patients with advanced pancreatic cancer. Br J Cancer 108(10): 2063-2069, 2013.
11. Schrodi S, Engel J and Schubert-Fritschle G: Manual mammakarzinom, epidemiologie. I. Bauerfeind, pp. 1-11, 2013.
12. Prokopchuk O, Liu Y, Henne-Bruns D and Kornmann M: Interleukin-4 enhances proliferation of human pancreatic cancer cells: Evidence for autocrine and paracrine actions. Br J Cancer 92(5): 921-928, 2005.
13. Formentini A, Braun P, Fricke H, Link KH, Henne-Bruns D and Kornmann M: Expression of interleukin-4 and interleukin-13 and their receptors in colorectal cancer. Int J Colorectal Dis 27(10): 1369-1376, 2012.
14. Li Z, Jiang J, Wang Z, Zhang J, Xiao M, Wang C, Lu Y and Qin Z: Endogenous interleukin-4 promotes tumor development by increasing tumor cell resistance to apoptosis. Cancer Res 68(21): 8687-8694, 2008.
15. Lee EJ, Lee SJ, Kim S, Cho SC, Choi YH, Kim WJ and Moon SK: Interleukin-5 enhances the migration and invasion of bladder cancer cells via ERK1/2-mediated MMP-9/NFkappaB/ AP-1 pathway: Involvement of the P21WAF1 expression. Cell Signal 25(10): 2025-2038, 2013.
16. Culig Z: Proinflammatory cytokine interleukin-6 in prostate carcinogenesis. Am J Clin Exp Urol 2(3): 231-238, 2014.
17. Li X, Wang Y, Han C, Li P and Zhang H: Colorectal cancer progression is associated with accumulation of Th17 lymphocytes in tumor tissues and increased serum levels of interleukin-6. Tohoku J Exp Med 233(3): 175-182, 2014.
18. Zarogoulidis P, Katsikogianni F, Tsiouda T, Sakkas A, Katsikogiannis N and Zarogoulidis K: Interleukin-8 and interleukin-17 for cancer. Cancer Invest 32(5): 197-205, 2014.
19. Yin J, Zeng F, Wu N, Kang K, Yang Z and Yang H: Interleukin-8 promotes human ovarian cancer cell migration by epithelial-mesenchymal transition induction in vitro. Clin Transl Oncol 17(5): 365-370, 2014.
20. Ranasinghe C, Trivedi S, Wijesundara DK and Jackson RJ: Il-4 and il-13 receptors: Roles in immunity and powerful vaccine adjuvants. Cytokine Growth Factor Rev 25(4): 437-442, 2014.
21. Formentini A, Prokopchuk O, Strater J, Kleeff J, Grochola LF, Leder G, Henne-Bruns D, Korc M and Kornmann M: Interleukin-13 exerts autocrine growth-promoting effects on human pancreatic cancer, and its expression correlates with a propensity for lymph node metastases. Int J Colorectal Dis 24(1): 57-67, 2009.